Oragenics Correlations

OGEN Stock  USD 0.65  0.01  1.52%   
The current 90-days correlation between Oragenics and AIM ImmunoTech is 0.08 (i.e., Significant diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Oragenics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Oragenics moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Oragenics Correlation With Market

Excellent diversification

The correlation between Oragenics and DJI is -0.58 (i.e., Excellent diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Oragenics and DJI in the same portfolio, assuming nothing else is changed.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Oragenics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in discontinued.
To learn how to invest in Oragenics Stock, please use our How to Invest in Oragenics guide.

Moving together with Oragenics Stock

  0.79EDIT Editas Medicine Earnings Call This WeekPairCorr
  0.68EVGN EvogenePairCorr
  0.62ABP Abpro HoldingsPairCorr
  0.8QSI QuantumSiPairCorr
  0.64GNLX Genelux CommonPairCorr
  0.67IMRN Immuron Ltd ADRPairCorr
  0.67MBIO Mustang BioPairCorr
  0.81ACXP Acurx Pharmaceuticals LLCPairCorr

Moving against Oragenics Stock

  0.77DSGN Design TherapeuticsPairCorr
  0.55IMMP Immutep Ltd ADRPairCorr
  0.47ENGN enGene Holdings CommonPairCorr
  0.36KYTX Kyverna TherapeuticsPairCorr
  0.3163E ONWARD MEDICAL BVPairCorr
  0.75AVE Avecho BiotechnologyPairCorr
  0.72SLDB Solid Biosciences LLCPairCorr
  0.6ANNX AnnexonPairCorr
  0.47SVRA Savara Inc Buyout TrendPairCorr
  0.44MRKR Marker TherapeuticsPairCorr
  0.76SMFG Sumitomo Mitsui Financial Sell-off TrendPairCorr
  0.76SMFNF Sumitomo Mitsui Financial Normal TradingPairCorr
  0.67MZHOF Mizuho Financial Normal TradingPairCorr
  0.66MFG Mizuho FinancialPairCorr

Related Correlations Analysis


Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

CANFENSC
ENSCAIM
CNSPAIM
SNGXKALA
CANFAIM
CNSPSNGX
  

High negative correlations

TTNPCNSP
TTNPKZIA
TTNPQLGN
TTNPXBIO
TTNPAIM
TTNPCANF

Risk-Adjusted Indicators

There is a big difference between Oragenics Stock performing well and Oragenics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Oragenics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
AIM  4.52 (1.06) 0.00 (0.70) 0.00 
 7.69 
 32.69 
KALA  6.25 (0.74) 0.00 (0.37) 0.00 
 12.28 
 59.48 
ENSC  5.13 (2.22) 0.00 (1.60) 0.00 
 10.64 
 60.48 
SNGX  3.46 (0.40) 0.00 (0.16) 0.00 
 8.16 
 30.10 
QLGN  5.09 (0.59) 0.00  2.34  0.00 
 10.42 
 26.37 
CANF  5.06 (0.60) 0.00  0.45  0.00 
 10.40 
 38.42 
XBIO  3.13 (0.10) 0.00 (0.05) 0.00 
 4.96 
 20.89 
CNSP  3.59 (0.80) 0.00 (0.99) 0.00 
 7.22 
 31.54 
KZIA  8.15 (0.18) 0.01  0.03  10.28 
 14.69 
 78.79 
TTNP  3.46  0.25  0.03  1.30  5.38 
 9.38 
 30.41 

Oragenics Corporate Management

Martin MScVP ResearchProfile
MD MAChief AdvisorProfile
IV FACEPChief OfficerProfile
Erik EmersonChief OfficerProfile
Michael CPAS CFOProfile